2003
CMS Decision Leaves Some Seniors Without Coverage for Now Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that an arbitration panel entered a preliminary finding that...
International Symposium Offers Unique Opportunity for Experts in Device and Drug Therapies to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored by...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
New Trial Signifies Continued Leadership in Heart Failure Clinical Science Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Guidant's Institute for Therapy Advancement - Japan Continues Leadership in Medical Education Indianapolis, Ind. and Tokyo, Japan - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
State-of-the-Art Simulation Programs Expand Guidant''s Medical Education Offerings to Physicians Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the...
Meeting to be held in Indianapolis on May 19 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
New Indication Allows Physicians to Harvest Artery in Arm For Coronary Bypass Graft Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the...
Landmark Trials Featured Indianapolis, Ind. and St. Paul, Minn. - Two Guidant Corporation (NYSE: GDT) sponsored clinical trials will be prominently featured during the 24th annual meeting of the...